42 results on '"Lenting, Peter J."'
Search Results
2. Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy
3. ANGIOPOIETIN-2 BINDS TO MULTIPLE INTERACTIVE SITES WITHIN VON WILLEBRAND FACTOR
4. IdeS, a new option to optimize the management of patients with hemophilia A on emicizumab
5. Antithrombin-lowering in hemophilia: A closer look at fitusiran
6. VON WILLEBRAND FACTOR: FROM FIGURANT TO MAIN CHARACTER IN THE SCENE OF INFLAMMATION
7. Antithrombotic potential of a single‐domain antibody enhancing the activated protein C‐cofactor activity of protein S
8. Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization
9. Osteoprotegerin modulates platelet adhesion to von Willebrand factor during release from endothelial cells
10. TaSER: Combining forces to stop the clot
11. In vivo modulation of a dominant‐negative variant in mouse models of von Willebrand disease type 2A
12. Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID‐19: Response from Original Authors Susen, et al.
13. Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID‐19
14. Camelid‐derived single‐chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications
15. Development and characterization of single‐domain antibodies neutralizing protease nexin‐1 as tools to increase thrombin generation
16. A single‐domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor
17. Emicizumab and thrombosis: The story so far
18. von Willebrand Factor and Management of Heart Valve Disease
19. Real-Time Monitoring of von Willebrand Factor in the Catheterization Laboratory
20. Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support
21. Antibody-Based Protection of von Willebrand Factor Degradation
22. Active von Willebrand factor and the risk of stroke
23. Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, α2-macroglobulin, factor IXa and factor VIII
24. Shielding of the A1 Domain by the D′D3 Domains of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V
25. Binding of Low Density Lipoprotein to Platelet Apolipoprotein E Receptor 2′ Results in Phosphorylation of p38MAPK
26. LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms
27. An Experimental Model to Study the in Vivo Survival of von Willebrand Factor
28. β2-Glycoprotein I and LDL-receptor family members
29. Dimers of β2-Glycoprotein I Increase Platelet Deposition to Collagen via Interaction with Phospholipids and the Apolipoprotein E Receptor 2′
30. Mapping the Collagen-binding Site in the von Willebrand Factor-A3 Domain
31. Low Density Lipoprotein Receptor-related Protein and Factor IXa Share Structural Requirements for Binding to the A3 Domain of Coagulation Factor VIII
32. Residues Phe342–Asn346 of Activated Coagulation Factor IX Contribute to the Interaction with Low Density Lipoprotein Receptor-related Protein
33. The Connecting Segment between Both Epidermal Growth Factor-like Domains in Blood Coagulation Factor IX Contributes to Stimulation by Factor VIIIa and Its Isolated A2 Domain
34. The α-Chains of C4b-binding Protein Mediate Complex Formation with Low Density Lipoprotein Receptor-related Protein
35. Hydrophobic Contact between the Two Epidermal Growth Factor-like Domains of Blood Coagulation Factor IX Contributes to Enzymatic Activity
36. Electron Crystallography of Human Blood Coagulation Factor VIII Bound to Phospholipid Monolayers
37. Surface Loop 199–204 in Blood Coagulation Factor IX Is a Cofactor-dependent Site Involved in Macromolecular Substrate Interaction
38. The Light Chain of Factor VIII Comprises a Binding Site for Low Density Lipoprotein Receptor-related Protein
39. Ca2+ Binding to the First Epidermal Growth Factor-like Domain of Human Blood Coagulation Factor IX Promotes Enzyme Activity and Factor VIII Light Chain Binding
40. The Sequence Glu1811-Lys1818 of Human Blood Coagulation Factor VIII Comprises a Binding Site for Activated Factor IX
41. Cleavage at Arginine 145 in Human Blood Coagulation Factor IX Converts the Zymogen into a Factor VIII Binding Enzyme
42. The Role of Cleavage of the Light Chain at Positions Arg1689 or Arg1721 in Subunit Interaction and Activation of Human Blood Coagulation Factor VIII
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.